Management of Microcytic Anemia
Initial Diagnostic Evaluation
- The American Gastroenterological Association recommends that serum ferritin is the most specific test for iron deficiency in the absence of inflammation, with levels <30 μg/L indicating iron deficiency 1
- In the presence of inflammation, serum ferritin up to 100 μg/L may still be consistent with iron deficiency, according to the Journal of Crohn's and Colitis 4
- A low MCV with elevated red cell distribution width (RDW >14.0%) suggests iron deficiency anemia, as stated by Praxis Medical Insights 3
- The European Crohn’s and Colitis Organisation suggests that a low MCV with normal RDW (≤14.0%) suggests thalassemia trait 3
Differential Diagnosis
- Anemia of chronic disease is characterized by low iron, low TIBC, and normal/high ferritin, as described by Praxis Medical Insights 2, 3
- Genetic disorders of iron metabolism or heme synthesis, such as SLC11A2 defects, should be considered in patients with unexplained microcytic anemia with increased TSAT, according to Blood 5, 6
Investigation of Underlying Causes
- The American College of Gastroenterology recommends investigating for gastrointestinal blood loss as it is the most common cause of iron deficiency anemia in men and post-menopausal women 1
- Other causes to consider include menstrual blood loss in pre-menopausal women, malabsorption, poor dietary intake, previous gastrectomy, and NSAID use, as stated by Gut 1
Treatment Approach
- The American College of Physicians recommends first-line treatment with oral iron supplementation for at least three months after correction of anemia, with ferrous sulfate 200 mg three times daily as standard dosing 3
- Adding ascorbic acid can enhance iron absorption, according to Praxis Medical Insights 2, 3
- For patients who fail to respond to oral iron therapy, consider intravenous (IV) iron if there is malabsorption, as suggested by Praxis Medical Insights 3
Monitoring and Follow-up
- The American Society of Hematology recommends monitoring hemoglobin concentration and red cell indices at three-month intervals for one year and then after a further year 3
- In patients receiving iron therapy for genetic disorders, monitor iron status to detect toxic iron loading early, as stated by Blood 5
Special Considerations
- Genetic testing should be considered in patients with refractory microcytic anemia despite adequate iron supplementation, according to Praxis Medical Insights 3
- Family screening may be recommended for patients diagnosed with genetic disorders affecting iron metabolism, as suggested by Blood and Praxis Medical Insights 3, 5